Filing Details
- Accession Number:
- 0000899243-21-036577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-20 16:05:10
- Reporting Period:
- 2021-04-05
- Accepted Time:
- 2021-09-20 16:05:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1754068 | Allovir Inc. | ALVR | Biological Products, (No Disgnostic Substances) (2836) | 831971007 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818064 | Agustin Melian | C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-05 | 18,212 | $23.89 | 498,304 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-07-02 | 18,586 | $19.99 | 479,718 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-15 | 800 | $24.03 | 478,918 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-17 | 2,950 | $24.01 | 475,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
